Amarin Corp Plc (AMRN)

[DeepBreath]

Amarin will cancel conference if the FDA does not provide definitive responses prior to conference.

From Amarincorp.com

As previously disclosed, the FDA has communicated its plan to respond to Amarin on the SPA reinstatement question not later than January 15, 2014 and the FDA has not informed Amarin of the date on which it will make its determination on the ANCHOR sNDA. Because Amarin and the FDA may engage in sensitive dialogue related to such ongoing matters during such time, Amarin does not currently plan to meet with investors or to have discussions with investors until after Amarin makes an appropriate public disclosure following significant updates from the FDA. Amarin is currently scheduled to present at the J.P. Morgan annual healthcare investor conference in mid-January 2014. If the FDA has not provided Amarin with definitive responses a reasonable time before such scheduled presentation, Amarin plans to cancel such presentation.